NoreenBukhari-ParlakturkMDPhD

Movement Disorder

Assistant Professor

Dr. Bukhari-Parlakturk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Duke University HospitalFellowship, Neuromuscular Medicine (Neurology), 2017 - 2018
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Neurology, 2014 - 2017
Stony Brook Medicine/University HospitalInternship, Internal Medicine, 2013 - 2014
Icahn School of Medicine at Mount SinaiPost-Doctoral Fellowship, 2012 - 2013
Stony Brook University Health Sciences Center School of MedicineClass of 2012

PubMed

Towards accredited clinical training in brain stimulation: Proceedings from the brain stimulation subspecialty summits.
Shan H Siddiqi, Leo Chen, Nicholas T Trapp, Noreen Bukhari-Parlakturk, Joseph J Taylor
Brain Stimulation. 2025-02-21
Motor network reorganization associated with rTMS-induced writing improvement in writer's cramp dystonia.
Noreen Bukhari-Parlakturk, Patrick J Mulcahey, Michael W Lutz, Rabia Ghazi, Ziping Huang
Brain Stimulation. 2025-02-07
Reduced auditory perception and brain response with quiet TMS coil.
David L K Murphy, Lari M Koponen, Eleanor Wood, Yiru Li, Noreen Bukhari-Parlakturk
Brain Stimulation. 2024-10-10

Journal Articles

Unmasking Proteolytic Actvity for Adult Visual Cortex Plasticity by the Removal of Lynx1
Bukhari N, Burman PN, Hussein A, Demars MP, Sadahiro M, Brady DM, Tsirka SE, Russo SJ, Morishita H, J of Neuroscience, 9/16/2015
Axonal growth after spinal cord injury via chondroitinase and the tissue plasminogen activator (tPA)/plasmin system
Bukhari N, Torres L, Robinson JK, Tsirka SE, J of Neuroscience, 10/19/2011
tPA-mediated generation of plasmin is catalyzed by the proteoglycan NG2
Nolin WB, Emmetsberger J, Bukhari N, Zhang Y, Levine JM, Tsirka SE, Glia, 1/15/2008
NAAG peptidase inhibition reduces locomoter activity and some stereotypes in the PCP model of schizophrenia via group II mGluR
Olszewski RT, Bukhari N, Zhou J, Kozikowski AP, Wroblewski JT, Shamimi-Noori S, Wroblewska B, Bzdega T, Vicini S, Barton FB, Neale JH, J Neurochemistry, 5/2004
Deletion of the glutamate carboxypeptidase II gene in mice reveales a second enzyme activity that hydrolzes N-acetylaspartylglutamate
Babich DJ, Ramadan E, O'Keefe DS, Bukhari N, Wegorzewska I, Ojeifo O, Olszewski R, Wrenn CC, Bzdega T, Wroblewska B, Heston WD, Neale JH, J Neurochemistry, 10/2002
Join now to see all